Cargando…

Liposome bupivacaine for improvement in economic outcomes and opioid burden in GI surgery: IMPROVE Study pooled analysis

Postsurgical pain management remains a significant challenge. Liposome bupivacaine, as part of a multimodal analgesic regimen, has been shown to significantly reduce postsurgical opioid consumption, hospital length of stay (LOS), and hospitalization costs in gastrointestinal (GI) surgery, compared w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Stephen M, Vogel, Jon D, Marcet, Jorge E, Candiotti, Keith A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075953/ https://www.ncbi.nlm.nih.gov/pubmed/25018650 http://dx.doi.org/10.2147/JPR.S63764

Ejemplares similares

Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes()
por: Candiotti, Keith A., et al.
Publicado: (2013)

Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia
por: Bergese, Sergio D, et al.
Publicado: (2012)

An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liPosome foRmulation Of bupiVacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal
por: Marcet, Jorge E, et al.
Publicado: (2013)

Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial
por: Vogel, Jon D
Publicado: (2013)

Association of Liposomal Bupivacaine on Opioid Consumption in the Pediatric Alveolar Cleft Population
por: Crowley, Jiwon Sarah, et al.
Publicado: (2019)

Economic Outcomes and Incidence of Postsurgical Hypotension With Liposomal Bupivacaine vs Epidural Analgesia in Abdominal Surgeries
por: Holtz, Margaret, et al.
Publicado: (2022)

Liposomal bupivacaine reduces opioid requirements following Ravitch repair for pectus excavatum
por: Abbasi, Rania K., et al.
Publicado: (2023)

The use of liposomal bupivacaine in fracture surgery: a review
por: Gailey, Andrew D., et al.
Publicado: (2023)

Long-acting liposomal bupivacaine and postoperative opioid use after Peyronie’s disease surgery: a pilot study
por: Britton, Cameron J., et al.
Publicado: (2021)

Abstract: Liposomal Bupivacaine in Implant-Based Breast Reconstruction: Patient Outcomes and Economics
por: Motakef, Saba, et al.
Publicado: (2016)

Liposomal bupivacaine: a review of a new bupivacaine formulation
por: Chahar, Praveen, et al.
Publicado: (2012)

Can Liposomal Bupivacaine Be Safely Utilized in Elective Spine Surgery?
por: Brown, Luke, et al.
Publicado: (2018)

Retrospective analysis of quality improvement when using liposome bupivacaine for postoperative pain control
por: King, Nicole M, et al.
Publicado: (2016)

Treatment of Digital Ischemia with Liposomal Bupivacaine
por: Raul Soberón, José, et al.
Publicado: (2014)

Erector Spinae Plane Blocks With Liposomal Bupivacaine for Pediatric Scoliosis Surgery
por: Stondell, Casey, et al.
Publicado: (2022)

172. A Retrospective Study Of Liposomal Bupivacaine Versus Conventional Bupivacaine On Opioid Use And Healthcare Resource Utilization Following Diep Flap Breast Reconstruction
por: Knackstedt, Rebecca, et al.
Publicado: (2023)

Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
por: Farmer, Travis, et al.
Publicado: (2020)

Liposomal extended-release bupivacaine for postsurgical analgesia
por: Lambrechts, Mark, et al.
Publicado: (2013)

Liposomal Bupivacaine in Implant-Based Breast Reconstruction
por: Motakef, Saba, et al.
Publicado: (2017)

Emerging roles of liposomal bupivacaine in anesthesia practice
por: Malik, Obaid, et al.
Publicado: (2017)

Are reinfusion drains safe to use with periarticular liposomal bupivacaine? An analysis of systemic bupivacaine toxicity
por: Angerame, Marc R., et al.
Publicado: (2017)

Bupivacaine Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine Administered After Cesarean Birth
por: Mustafa, Hiba J., et al.
Publicado: (2020)

Patient Complications after Interscalene Block: A Retrospective Comparison of Liposomal Bupivacaine to Nonliposomal Bupivacaine
por: Hutchins, Jacob L., et al.
Publicado: (2020)

Comparison of Transversus Abdominis Plane Infiltration with Liposomal Bupivacaine versus Continuous Epidural Analgesia versus Intravenous Opioid Analgesia
por: Ayad, Sabry, et al.
Publicado: (2016)

A multimodal protocol utilizing liposomal bupivacaine rib blocks leads to opioid reduction in patients undergoing the Nuss procedure
por: Eubanks, Alicia L., et al.
Publicado: (2021)

Impact of volume expansion on the efficacy and pharmacokinetics of liposome bupivacaine
por: Hadzic, Admir, et al.
Publicado: (2015)

Abstract: Liposome Bupivacaine for Postoperative Pain Control for Labiaplasty
por: Fukuzawa, Minako, et al.
Publicado: (2018)

Periarticular injection of liposomal bupivacaine in total knee arthroplasty
por: Webb, Bradley T., et al.
Publicado: (2015)

Does Subcutaneous Infiltration of Liposomal Bupivacaine Following Single-Level Transforaminal Lumbar Interbody Fusion Surgery Improve Immediate Postoperative Pain Control?
por: Tomov, Marko, et al.
Publicado: (2018)

Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
por: Snyder, Mark A., et al.
Publicado: (2016)

Clinical and Economic Outcomes Associated With Use of Liposomal Bupivacaine Versus Standard of Care for Management of Postsurgical Pain in Pediatric Patients Undergoing Spine Surgery
por: Ballock, Robert Tracy, et al.
Publicado: (2021)

Neurotoxicity of bupivacaine and liposome bupivacaine after sciatic nerve block in healthy and streptozotocin-induced diabetic mice
por: Markova, Liljana, et al.
Publicado: (2020)

Correction: Comparison of Transversus Abdominis Plane Infiltration with Liposomal Bupivacaine versus Continuous Epidural Analgesia versus Intravenous Opioid Analgesia
por: Ayad, Sabry, et al.
Publicado: (2016)

Liposomal bupivacaine does not decrease postoperative opioid use or length of hospital stay in patients undergoing anterior cervical discectomy and fusion
por: Neufeld, Eric V., et al.
Publicado: (2022)

Safety of liposome extended-release bupivacaine for postoperative pain control
por: Portillo, Juan, et al.
Publicado: (2014)

The safety of liposome bupivacaine following various routes of administration in animals
por: Joshi, Girish P, et al.
Publicado: (2015)

Economic Burden of Prescription Opioid Misuse and Abuse
por: Strassels, Scott
Publicado: (2009)

Time to Analgesia Onset and Pharmacokinetics After Separate and Combined Administration of Liposome Bupivacaine and Bupivacaine HCl: Considerations for Clinicians
por: Gadsden, Jeffrey, et al.
Publicado: (2016)

Liposomal bupivacaine versus traditional bupivacaine for pain control after total hip arthroplasty: A meta-analysis
por: Ma, Ting-Ting, et al.
Publicado: (2017)

Epidural bupivacaine administration after infiltration of liposomal bupivacaine for transversalis fascia plane block: A case report
por: Harbell, Monica W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3a42hvcm7chlfadb8qtq2cdtr